Picture of PCI Biotech Holding ASA logo

PCIBo — PCI Biotech Holding ASA News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapNeutral

Brief: PCI Biotech Holding successful completion of the third dose cohort

Aug 18 (Reuters) - PCI Biotech Holding ASA  PCIB.OL : 
    
    * Successful completion of the third dose cohort in the 
study for patients with inoperable bile duct cancer 
    * No safety concerns were observed at this dose level 
 
Source text for Eikon:  ID:nHUG4ZHygd  
    
Further company coverage:  PCIB.OL  
 
 (Gdynia Newsroom) 
 ((gdynia.newsroom@thomsonreuters.com; +48586983920;))

Recent news on PCI Biotech Holding ASA

See all news